f Accelerating Rheumatoid Arthritis Drug Repurposing: A Computational Approach

References

1. SinghN. VayerP. TanwarS. PoyetJ.L. TsaiounK. VilloutreixB.O. Drug discovery and development: introduction to the general public and patient groups.Frontiers in Drug Discovery20233120141910.3389/fddsv.2023.1201419
   [Google Scholar]
2. PognanF. BeilmannM. BoonenH.C.M. CzichA. DearG. HewittP. MowT. OinonenT. RothA. Steger-HartmannT. ValentinJ.P. Van GoethemF. WeaverR.J. NewhamP. The evolving role of investigative toxicology in the pharmaceutical industry.Nat. Rev. Drug Discov.202322431733510.1038/s41573‑022‑00633‑x 36781957
   [Google Scholar]
3. ZhouS.F. ZhongW.Z. Drug Design and Discovery: Principles and Applications.Molecules201722227910.3390/molecules22020279 28208821
   [Google Scholar]
4. XuY. LiuX. CaoX. HuangC. LiuE. QianS. LiuX. WuY. DongF. QiuC.W. QiuJ. HuaK. SuW. WuJ. XuH. HanY. FuC. YinZ. LiuM. RoepmanR. DietmannS. VirtaM. KengaraF. ZhangZ. ZhangL. ZhaoT. DaiJ. YangJ. LanL. LuoM. LiuZ. AnT. ZhangB. HeX. CongS. LiuX. ZhangW. LewisJ.P. TiedjeJ.M. WangQ. AnZ. WangF. ZhangL. HuangT. LuC. CaiZ. WangF. ZhangJ. Artificial intelligence: A powerful paradigm for scientific research.Innovation20212410017910.1016/j.xinn.2021.100179 34877560
   [Google Scholar]
5. Jiménez-LunaJ. GrisoniF. WeskampN. SchneiderG. Artificial intelligence in drug discovery: recent advances and future perspectives.Expert Opin. Drug Discov.202116994995910.1080/17460441.2021.1909567 33779453
   [Google Scholar]
6. KlareskogL. RönnelidJ. SaevarsdottirS. PadyukovL. AlfredssonL. The importance of differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis.J. Intern. Med.2020287551453310.1111/joim.13058 32176395
   [Google Scholar]
7. YapH.Y. TeeS.Z.Y. WongM.M.T. ChowS.K. PehS.C. TeowS.Y. Pathogenic role of immune cells in rheumatoid arthritis: Implications in clinical treatment and biomarker development.Cells201871016110.3390/cells7100161 30304822
   [Google Scholar]
8. DerksenV.F.A.M. HuizingaT.W.J. van der WoudeD. The role of autoantibodies in the pathophysiology of rheumatoid arthritis.Semin. Immunopathol.201739443744610.1007/s00281‑017‑0627‑z 28451788
   [Google Scholar]
9. van DelftM.A.M. HuizingaT.W.J. An overview of autoantibodies in rheumatoid arthritis.J. Autoimmun.202011010239210.1016/j.jaut.2019.102392 31911013
   [Google Scholar]
10. CurranA.M. NaikP. GilesJ.T. DarrahE. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.Nat. Rev. Rheumatol.202016630131510.1038/s41584‑020‑0409‑1 32341463
    [Google Scholar]
11. Gómez-BañuelosE. MukherjeeA. DarrahE. AndradeF. Rheumatoid arthritis-associated mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.J. Clin. Med.201989130910.3390/jcm8091309 31454946
    [Google Scholar]
12. GanD. ChengW. KeL. SunA.R. JiaQ. ChenJ. LinJ. LiJ. XuZ. ZhangP. Repurposing of pirfenidone (Anti-Pulmonary Fibrosis Drug) for treatment of rheumatoid arthritis.Front. Pharmacol.20211263189110.3389/fphar.2021.631891 33746759
    [Google Scholar]
13. de HairM.J.H. van de SandeM.G.H. RamwadhdoebeT.H. HanssonM. LandewéR. van der LeijC. MaasM. SerreG. van SchaardenburgD. KlareskogL. GerlagD.M. van BaarsenL.G.M. TakP.P. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis.Arthritis Rheumatol.201466351352210.1002/art.38273 24574210
    [Google Scholar]
14. SchwartzD.M. KannoY. VillarinoA. WardM. GadinaM. O’SheaJ.J. Erratum: JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Nat. Rev. Drug Discov.20181717810.1038/nrd.2017.267 29282366
    [Google Scholar]
15. WuC.Y. YangH.Y. LuoS.F. LaiJ.H. From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.Int. J. Mol. Sci.202122268610.3390/ijms22020686 33445768
    [Google Scholar]
16. DaraS. DhamercherlaS. JadavS.S. BabuC.H.M. AhsanM.J. Machine Learning in Drug Discovery: A Review.Artif. Intell. Rev.20225531947199910.1007/s10462‑021‑10058‑4 34393317
    [Google Scholar]